pipeline. GB001 Phase 2 clinical program* GB002 Phase 1 clinical program* GB003 Preclinical program* GB004 First-in-class, HIF-1α stabilizer, for the treatment of inflammatory bowel diseases – Phase 1 clinical program *Targets to be disclosed
